Synthetic lethal interaction of CDK inhibition and autophagy inhibition in human solid cancer cell lines

Cell cycle control is a promising target in cancer treatments, and some small-molecule cyclin-dependent kinase (CDK) inhibitors have exhibited clinical effectiveness. However, no biomarkers predictive of efficacy have been developed. Recent studies have revealed that CDK inhibitor (CKI) proteins, su...

Descripción completa

Detalles Bibliográficos
Autores principales: Okada, Yoshinari, Kato, Shunsuke, Sakamoto, Yasuhiro, Oishi, Takayuki, Ishioka, Chikashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492844/
https://www.ncbi.nlm.nih.gov/pubmed/28560460
http://dx.doi.org/10.3892/or.2017.5684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492844/
https://www.ncbi.nlm.nih.gov/pubmed/28560460
http://dx.doi.org/10.3892/or.2017.5684

Ejemplares similares